Application Nr Approved Date Route Status External Links
ANDA201464 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications & Usage Levetiracetam Extended-Release Tablets Is Indicated As Adjunctive Therapy In The Treatment Of Partial Onset Seizures In Patients > 16 Years Of Age With Epilepsy.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Levetiracetam LEVETIRACETAM ZINC1547851

Comments